Appraise-2
Laufzeit: 01.01.2009 - 31.12.2011
imported
Kurzfassung
A Phase 3. Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban in Subjects with a Recent Acute Coronary Syndrome
Laufzeit: 01.01.2009 - 31.12.2011
A Phase 3. Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban in Subjects with a Recent Acute Coronary Syndrome
